\-\ Texto\\:\\ \ \(0\)\
\-\ pe\\:\\ mild\\ bilateral\\ flank\\ pain\\.\ \(0\)\
\-\ labs\\:\\ elevated\\ serum\\ calcium\\.\ \(0\)\
\-\ to\\ follow\\.\ \(3\)\
\-\ 1\\.\\ lungs\\ with\\ reticulonodular\\ interstitial\\ pattern\\.\ \(0\)\
\-\ 2\\.\\ nephrolithiasis\\.\ \(0\)\
\-\ 3\\.\\ diffuse\\ lymphadenopathy\\.\ \(0\)\
\-\ sarcoidosis\\.\ \(14\)\
\-\ tuberculosis\\ \ \(30\)\
\-\ \\ lymphoma\\ \\-\\ almost\\ never\\ shows\\ the\\ striking\\ symmetry\\ \ \(0\)\
\-\ \\ carcinoma\\ \\(metastatic\\)\\ \ \(0\)\
\-\ \\ sarcoid\ \(138\)\
\-\ \\ fungal\\ disease\ \(3\)\
\-\ 34\\ year\\ old\\ female\\ presents\\ to\\ the\\ emergency\\ room\\ with\\ abdominal\\ pain\\.\ \(1\)\
\-\ the\\ patient\\ presented\\ with\\ abdominal\\ pain\\ secondary\\ to\\ bilateral\\ nephrolithiasis\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ nephrolithiasis\\:\\ 0\\.13975913305689547\ \(0\)\
\-\ symmetry\\:\\ 0\\.09355662336509253\ \(0\)\
\-\ reticulonodular\\:\\ 0\\.08392957919064883\ \(0\)\
\-\ striking\\:\\ 0\\.0808303632001737\ \(0\)\
\-\ never\\:\\ 0\\.06987956652844773\ \(0\)\
\-\ sarcoid\\:\\ 0\\.060898633682266445\ \(0\)\
\-\ abdominal\\:\\ 0\\.059331089947836535\ \(0\)\
\-\ 34\\:\\ 0\\.05890010340920993\ \(0\)\
\-\ calcium\\:\\ 0\\.058066519940789756\ \(0\)\
\-\ interstitial\\:\\ 0\\.058066519940789756\ \(0\)\
\-\ bilateral\\:\\ 0\\.05760604803651233\ \(0\)\
\-\ fungal\\:\\ 0\\.057537355409785995\ \(0\)\
\-\ almost\\:\\ 0\\.05740815551169831\ \(0\)\
\-\ serum\\:\\ 0\\.05728014641301882\ \(0\)\
\-\ tuberculosis\\:\\ 0\\.05653592077226733\ \(0\)\
\-\ flank\\:\\ 0\\.05582955386624662\ \(0\)\
\-\ sarcoidosis\\:\\ 0\\.05360682453285052\ \(0\)\
\-\ pe\\:\\ 0\\.05331645391036005\ \(0\)\
\-\ room\\:\\ 0\\.05102576204810886\ \(0\)\
\-\ lymphadenopathy\\:\\ 0\\.050468539912144623\ \(0\)\
\-\ pattern\\:\\ 0\\.045367254709323304\ \(0\)\
\-\ lungs\\:\\ 0\\.044941508305281604\ \(0\)\
\-\ emergency\\:\\ 0\\.044941508305281604\ \(0\)\
\-\ pain\\:\\ 0\\.043483673647113946\ \(0\)\
\-\ labs\\:\\ 0\\.041277416762988024\ \(0\)\
\-\ 3\\.\\:\\ 0\\.040609364057510096\ \(0\)\
\-\ elevated\\:\\ 0\\.04026828279665365\ \(0\)\
\-\ 2\\.\\:\\ 0\\.037742279747225806\ \(0\)\
\-\ follow\\:\\ 0\\.0377111037770338\ \(0\)\
\-\ 1\\.\\:\\ 0\\.037072071754133344\ \(0\)\
\-\ diffuse\\:\\ 0\\.035930658616323816\ \(0\)\
\-\ lymphoma\\:\\ 0\\.03391942547763174\ \(0\)\
\-\ carcinoma\\:\\ 0\\.033637884305775925\ \(0\)\
\-\ secondary\\:\\ 0\\.03318097175706677\ \(0\)\
\-\ shows\\:\\ 0\\.032630190274012205\ \(0\)\
\-\ presented\\:\\ 0\\.03235218937531124\ \(0\)\
\-\ \\:\\:\\ 0\\.03139652266640736\ \(0\)\
\-\ mild\\:\\ 0\\.03125352019348801\ \(0\)\
\-\ metastatic\\:\\ 0\\.02987651949466792\ \(0\)\
\-\ \\-\\:\\ 0\\.025440673037616157\ \(0\)\
\-\ female\\:\\ 0\\.024399448214553244\ \(0\)\
\-\ presents\\:\\ 0\\.024245059659832303\ \(0\)\
\-\ disease\\:\\ 0\\.019399132516884778\ \(0\)\
\-\ to\\:\\ 0\\.01779450451845776\ \(0\)\
\-\ year\\:\\ 0\\.013279239851012703\ \(0\)\
\-\ old\\:\\ 0\\.012151869400864646\ \(0\)\
\-\ patient\\:\\ 0\\.0118971101516165\ \(0\)\
\-\ \\(\\:\\ 0\\.010032801753386951\ \(0\)\
\-\ \\)\\:\\ 0\\.009910245723795903\ \(0\)\
\-\ the\\:\\ 0\\.005760386862651075\ \(0\)\
\-\ with\\:\\ 0\\.004875174003745405\ \(0\)\
\-\ \\.\\:\\ 0\\.004437442012168284\ \(0\)\
